APLIF (Appili Therapeutics) Other Income (Expense) : $-0.41 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Other Income (Expense)?

Appili Therapeutics's other income expense for the Appili Therapeutics's pretax income for the three months ended in Dec. 2024 was $-0.36 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.41 Mil.

Appili Therapeutics Other Income (Expense) Historical Data

The historical data trend for Appili Therapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Other Income (Expense) Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Income (Expense)

Get a 7-Day Free Trial

0.04

-0.27

0.05

Appili Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial															0.10	-0.09	-0.04	0.09	-0.36

Appili Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.

Appili Therapeutics (OTCPK:APLIF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Appili Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.